
Sign up to save your podcasts
Or


In USAgainstAlzheimer's July Alzheimer’s Talks, Dr. Michael Rafii – Medical Director of the Alzheimer’s Disease Cooperative Study (ADCS), Director of the Memory Disorders Clinic and Assistant Professor of Neurosciences at the University of California, San Diego and Attending Neurologist at the Shiley-Marcos Alzheimer’s Disease Research Center – joined us to discuss his exciting work on the NOBLE and A4 studies, coordinated by the ADCS. With new imaging technology and a greater understanding of the progression of Alzheimer’s guiding clinical trials, there’s hope on the horizon for Alzheimer’s treatment and prevention.
Support the show (https://www.usagainstalzheimers.org)
By Meryl Comer, UsAgainstAlzheimer's4.7
1414 ratings
In USAgainstAlzheimer's July Alzheimer’s Talks, Dr. Michael Rafii – Medical Director of the Alzheimer’s Disease Cooperative Study (ADCS), Director of the Memory Disorders Clinic and Assistant Professor of Neurosciences at the University of California, San Diego and Attending Neurologist at the Shiley-Marcos Alzheimer’s Disease Research Center – joined us to discuss his exciting work on the NOBLE and A4 studies, coordinated by the ADCS. With new imaging technology and a greater understanding of the progression of Alzheimer’s guiding clinical trials, there’s hope on the horizon for Alzheimer’s treatment and prevention.
Support the show (https://www.usagainstalzheimers.org)
658 Listeners

3,451 Listeners

4,884 Listeners

3,082 Listeners

6,438 Listeners

4,888 Listeners

9,228 Listeners

8,183 Listeners

6,403 Listeners

58,029 Listeners

3,440 Listeners

10,517 Listeners

19,812 Listeners

166 Listeners

1,735 Listeners